Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.

Abstract

BACKGROUND Efavirenz and lopinavir boosted with ritonavir are both recommended as first-line therapies for patients with HIV when combined with two nucleoside reverse transcriptase inhibitors. It is uncertain which therapy is more effective for patients starting therapy with an advanced infection. METHODS We estimated the relative effect of these two… (More)
DOI: 10.3851/IMP1291

Topics

5 Figures and Tables